4 h. ago Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company’s Suite of Licenses and Proven U.S. Clinical Trial Supply Experience

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, welcomes U.S. President Donald Trump’s executive order  to expedite the reclassification of cannabis under the U.S. Controlled Substances Act from Schedule I to Schedule III (the […]

Economics

18 h. ago LEEF Brands Comments on Federal Cannabis Rescheduling and Potential to Participate in Nationwide CBD Program

VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — LEEF Brands, Inc. (CSE: LEEF, OTCQB: LEEEF) (“LEEF” or the “Company”), a leading multi-state operator, today commented on the issuance of an executive order by President Donald Trump directing agencies to begin the rescheduling of cannabis under the U.S. Controlled Substances Act. The executive order initiates […]

Culture

21 h. ago POSaBIT Applauds Today’s Executive Order to Reschedule Cannabis as a Pivotal Step Forward for the Industry

Move to Schedule III Expected to Bring in More Investment Interest and Capital to Publicly-Traded Companies Like POSaBIT TORONTO & SEATTLE — POSaBIT (CSE: PBIT, OTC: POSAF), a leading provider of point-of-sale and payments infrastructure for the cannabis industry, today expressed strong support for the federal government’s decision to reschedule cannabis from a Schedule I […]

Other

23 h. ago 'We're all on the same page' about protecting French, Marc Miller says

The federal minister doesn't regret his comments earlier this month despite backlash from politicians, including Premier François Legault.

Other

23 h. ago Cresco Labs CEO: Rescheduling Marks Historic Shift for Cannabis Industry

CHICAGO — Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell following President Trump’s action to reschedule cannabis from a Schedule I to Schedule III substance under the Controlled Substances Act. “Today marks the most consequential moment in […]

Other

23 h. ago Verano Founder and Chief Executive Officer George Archos Shares Celebratory Comments on Cannabis Rescheduling Announcement

Verano’s active operations span 13 states, comprised of 158 dispensaries operating under the Zen Leaf™ and MÜV™ retail banners, and 15 cultivation and processing facilities with more than 1.1 million square feet of cultivation capacity CHICAGO, Dec. 18, 2025 (GLOBE NEWSWIRE) — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a […]

Events

23 h. ago Tilray Accelerates U.S. Medical Cannabis Expansion After Landmark Federal Rescheduling: Launches Tilray Medical USA to Lead Nationwide Medical Cannabis Innovation and Growth

Global Cannabis Leader Poised for Major U.S. Market Entry, Signaling New Era for Healthcare NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) — Tilray Medical, a division of Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis healthcare, today confirmed its planned strategic framework to advance its […]

Other

7 d. ago Trump’s plan to push for cannabis rescheduling lifts pot stocks

Cannabis is currently labelled a Schedule I drug, putting it in the same category that includes substances like heroin and LSD

Economics

9 d. ago Quebec ready to offer financial 'advantages' to settle doctor dispute

Premier François Legault's comments follow last weekend's negotiating blitz with the federation representing general practitioners over Bill 2.

Science

2 w. ago LEEF Brands Announces Full Early Conversion of ~US$10.5 Million of USD Convertible Debentures

VANCOUVER, British Columbia, Dec. 05, 2025 (GLOBE NEWSWIRE) — LEEF Brands, Inc. (CSE: LEEF, OTCQB: LEEEF) (“LEEF” or the “Company”), a leading multi-state operator, today announced the full early conversion of its outstanding 11% secured convertible debentures due September 9, 2027, in principal amount together with accrued and unpaid interest of approximately US$10,588,928. The conversion […]

Economics

2 w. ago Ottawa dévoile son utilisation de l’IA dans un nouveau registre

Les Canadiens peuvent désormais savoir où, quand et comment l’IA est utilisée au sein de l’appareil fédéral.

Other

3 w. ago European Stocks Gain With Boost From Dovish Fed Comments, Bayer

European stocks gained as sentiment was lifted by dovish Federal Reserve comments and early talks about potential Nvidia Corp. chip sales to China. Bayer AG rallied after releasing promising study results.

Economics